1. Home
  2. NEWS
  3. Porosome Therapeutics Inc., CSO presented at the recent (April 4-7, 2024) American Physiological Society Meetings in Long Beach, CA, studies on porosome reconstitution therapy that overcomes Cystic Fibrosis (CF) both in human bronchial epithelial cells and in CF mice.

Porosome Therapeutics Inc., CSO presented at the recent (April 4-7, 2024) American Physiological Society Meetings in Long Beach, CA, studies on porosome reconstitution therapy that overcomes Cystic Fibrosis (CF) both in human bronchial epithelial cells and in CF mice.

Porosome Therapeutics Inc., CSO presented at the recent (April 4-7, 2024) American Physiological Society Meetings in Long Beach, CA, studies on porosome reconstitution therapy that overcomes Cystic Fibrosis (CF) both in human bronchial epithelial cells and in CF mice.
Porosome Therapeutics, Inc. Academic Chairman Prof. Bhanu P. Jena presented the Opening Ceremony and Keynote Lecture entitled: “The Porosome Secretory Nanomachine: Discovery to Therapy”, at the International Drug Discovery Science & Technology (IDDST) Congress in Kyoto, Japan
Porosome Therapeutics Unveils Groundbreaking Discovery in Alzheimer’s Disease Research and Treatment
Porosome Therapeutics, Inc. CEO and Chairman are Interviewed in Cambridge, MA